Contribution of prostanoids to endothelium-dependent vasodilatation in the digital circulation of women with primary Raynaud's disease

Clinical Science

Volumn 109, Issue 1, 2005, Pages 45-54

  Easter, Melanie J ^a   Marshall, Janice M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Acetylcholine; Cyclo oxygenase; Endothelium; Prostanoid; Raynaud's disease; Vasodilatation

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ESTROGEN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ERYTHROCYTE; FEMALE; FINGER; HUMAN; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; VASOCONSTRICTION; VASODILATATION; VASOSPASM;

ACETYLCHOLINE; ADULT; AGING; ANALYSIS OF VARIANCE; ASPIRIN; CASE-CONTROL STUDIES; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; FINGERS; HUMANS; IONTOPHORESIS; MENOPAUSE; MIDDLE AGED; PROSTAGLANDINS; RAYNAUD DISEASE; REGIONAL BLOOD FLOW; SKIN TEMPERATURE; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 21744455780     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040262     Document Type: Article

References (46)

1. Belch, J. J. F. (1990) The phenomenon, syndrome and disease of Maurice Raynaud. Br. J. Rheumatol. 29, 162-165
2. Lewis, T. (1938) Raynaud's disease and pre-ganglionic sympathectomy. Clin. Sci. 3, 320-336
3. Edwards, C. M., Marshall, J. M. and Pugh, M. (1998) Lack of habituation of the pattern of cardiovascular responses evoked by sound in subjects with Primary Raynaud's Disease. Clin. Sci. 95, 249-260
4. Edwards, C. M., Marshall, J. M. and Pugh, M. (1999) Cardiovascular responses evoked by mild cool stimuli in Primary Raynaud's Disease: the role of endothelin. Clin. Sci. 96, 577-588
5. 2 receptor hypersensitivity in Raynaud's phenomenon. J. Vasc. Med. Biol. 2, 100-106
6. 2- adrenoceptors as cutaneous thermosensors. News Physiol. Sci. 6, 251-255
7. Zamora, M. R., O'Brien, R. F., Rutherford, R. B. and Weil, J. V. (1990) Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet. 336, 1144-1147
8. Biondi, M. L., Marasini, B., Bassani, C. and Agostini, A. (1988) Increased plasma endothelin levels in patients with Raynaud's Phenomenon. N. Engl. J. Med. 324, 1139
9. Vanhoutte, P. M. (2000) Say NO to ET. J. Auton. Nerv. Syst. 81, 271-277
10. Khan, F., Litchfield, S. J., McLaren, M, Veale, D. J., Littleford, R. E. and Belch, J. J. (1997) Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthr. Rheum. 40, 352-357
11. Edwards, C. M., Marshall, J. M. and Pugh, M. (1999) Cutaneous responses to sodium nitroprusside but not those to acetylcholine may be impaired in patients with Primary Raynaud's Disease. Clin. Auton. Res. 9, 35
12. Busse, R., Edwards, G., Feleton, M., Fleming, I., Vanhoutte, P. M. and Weston, A. H. (2002) EDHF: bringing the concepts together. Trends Pharmacol. Sci. 23, 374-380
13. Heavey, D. L., Barrow, S. E., Hickling, N. E. and Retter, J. M. (1985) Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature (London) 318, 186-188
14. Morris, S. J. and Shore, A. C. (1996) Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J. Physiol. 496, 531-542
15. Noon, J. P., Walker, B. R., Hand, M. F. and Webb, D. J. (1998) Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic dilatation is mediated by dilator prostanoids rather than nitric oxide. Br. J. Clin. Pharmacol. 45, 545-550
16. Hendry, R. and Marshall, J. M. (2004) Vasoconstrictor products of cyclooxygenase activity limit acetylcholine-induced cutaneous vasodilatation in young male subjects. Clin. Sci. 107, 323-330
17. Maricq, H. R., Wennrich, M. C., Wiel, J. E. and LeRoy, E. C. (1986) Prevalence of Raynaud's phenomenon in the general population. J. Chron. Dis. 39, 423-427
18. Allen, E. and Brown, G. (1932) Raynaud's Disease: a critical review of minimal requisites for diagnosis. Am. J. Med. Sci. 183, 187-195
19. Kallenberg, C. G. M., Wouda, A. A., Hoet, M. H. and van Venrooy, W. J. (1988) Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow-up with emphasis on the predictive value of anti-nuclear antibodies as directed by immunoblotting. Ann. Rheum. Dis. 47, 634-641
20. Lafferty, K., de Trafford, J., Potter, C., Roberts, V. and Cotton, L. (1985) Reflex vascular responses in the finger to contralateral thermal stimuli during the normal menstrual cycle: a hormonal basis to Raynaud's Phenomenon? Clin. Sci. 68, 639-645
21. Bunker, C. B., Goldsmith, P. C., Leslie, T. A., Hayes, N., Foreman, J. C. and Dowd, P. M. (1996) Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon. Br. J. Dermatol. 134, 399-406
22. Anderson, M. E., Hollis, S., Moore, T., Jayson, M. I. and Herrick, A. L. (1996) Non-invasive assessment of vascular reactivity in forearm skin of patients with primary Raynaud's phenomenon and systemic sclerosis. Br. J. Rheumatol. 35, 1281-1288
23. Anderson, M. E., Campbell, F., Hollis, S., Moore, T., Jayson, M. I. and Herrick, A. L. (1999) Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud's phenomenon and systemic sclerosis. Clin. Exp. Rheumatol. 17, 49-54
24. Khan, F. and Coffman, J. D. (1994) Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon. Circulation 89, 1183-1188
25. Herrick, A. L., Illingworth, K., Blann, A., Hay, C. R., Hollis, S. and Jayson, M. I. (1996) Von Willebrand factor, thrombomodulin, thromboxane, β-thromoglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann. Rheum. Dis. 55, 122-127
26. Algotsson, A., Nordberg, A. and Winblad, B. (1995) Influence of age and gender on skin vessel reactivity to endothelium-dependent and endothelium-independent vasodilators tested on iontophoresis and a laser Doppler perfusion imager. J. Gerontol., Ser. A 50, M121-M127
27. Andrawis, N., Jones, D. S. and Abernethy, D. R. (2000) Aging is associated with endothelial dysfunction in the human forearm vasculature. J. Am. Geriat. Soc. 48, 193-198
28. Taddei, S., Virdis, A., Mattei, P. et al. (1995) Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91, 1981-1987
29. Taddei, S., Virdis, A., Ghiadoni, L. et al. (1996) Menopause is associated with endothelial dysfunction in women. Hypertension 28, 576-582
30. Taddei, S. (2000) Endothelial dysfunction in hypertension. J. Nephrol. 13, 205-210
31. Pinto, S., Virdis, A., Ghiadoni, L. et al. (1997) Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 29, 268-273
32. Abou-Elenin, K., Xydakis, A., Hamdy, O., Economides, P. A., Horton, E. S. and Veves, A. (2002) The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivity. Microvasc. Res. 63, 91-95
33. Khan, F., Davidson, N. C., Littleford, R. C., Litchfield, S. J., Struthers, A. D. and Belch, J. J. F. (1997) Cutaneous vascular responses to acetylcholine are mediated by a prostanoid-dependent mechanism in man. Vasc. Med. 2, 82-86
34. Taddei, S., Virdis, A., Mattei, P. et al. (1997) Hypertension causes premature aging of endothelial function in humans. Hypertension 29, 736-743
35. Virdis, A., Ghiadoni, L., Pinto, S. et al. (2000) Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation 101, 2258-2263
36. Katusic, K. S. and Shepherd, J. T. (1991) Endothelium-derived vasoactive factors: II endothelium-dependent contraction. Hypertension 18 (Suppl. III), 86-92
37. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension 15, 699-703
38. 2 in aorta of the spontaneously hypertensive rat. J. Cardiovasc. Pharmacol. 33, 605-610
39. Ayres, S., Abplanalp, W., Liu, J. H. and Ravi Subbiah, M. T. (1998) Mechanisms involved in the protective effect of estradiol-17β on lipid peroxidation and DNA damage. Am. J. Physiol. 274, E1002-E1008
40. Barbacanne, M. A., Kami, J., Michel, J. B. et al. (1999) Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc. Res. 41, 672-681
41. Chambliss, K. L. and Shaul, P. W. (2002) Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev. 23, 665-686
42. Jun, S. S., Chen, Z., Pace, M. C. and Shaul, P. W. (1998) Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. J. Clin. Invest. 102, 176-183
43. Fulton, C. T. and Stallone, J. N. (2002) Sexual dimorphism in prostanoid-potentiated vascular contraction: roles of endothelium and ovarian steroids. Am. J. Physiol. Heart Circ. Physiol. 283, H2062-H2073
44. Planchon, B., Pistorius, M. A., Beurrier, P. and de Faucal, P. (1994) Primary Raynaud's phenomenon: age of onset and pathogenesis in a prospective study of 424 patients. Angiology 45, 677-686
45. Fraenkel, L., Zhang, Y., Chaisson, C. E., Evans, S. R., Wilson, P. W. F. and Felson, D. T. (1998) The association of estrogen replacement therapy and Raynaud's phenomenon in post-menopausal women. Ann. Intern. Med. 129, 208-211
46. Taddei, S., Ghiadoni, L., Virdis, A., Buralli, S. and Salvetti, A. (1999) Vasodilation to bradykinin is mediated by an oubain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation 100, 1400-1405